Tenofovir
| |||||||
tenofovir | |||||||
| |||||||
Uses: | HIV/AIDS & Hep. B | ||||||
Properties: | RT inhibitor, adenosine analog | ||||||
Hazards: | see drug interactions | ||||||
|
Tenofovir is a nucleotide analog reverse transcritase inhibitor (nRTI) antiviral drug used to treat HIV/AIDS and is in clinical trials for treatment of hepatitis B infection. The triphosphate from of the drug competes with the natural DNA nucleotide deoxyadenosine triphosphate (dATP) during DNA formation and it acts as a DNA chain terminator once incorporated because it lacks the normal deoxyribose sugar needed for connecting to the next DNA base.
Chemistry
The IUPAC chemical name for tenofovir is [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid and it has chemical formula C9H14N5O4P, giving it a molecular mass of 287.2123 g/mol. It is chemically similar to the natural neucleotide adenosine but lacks a ribose sugar unit.
Synonyms and brand names
Synonyms
- Tenofovir disoproxil
- Tenofovir disoproxil fumarate
- D,L-Tenofovir
- TDF
- PMPA
Brand Names
- Apropovir
- Viread
External links
- Tenofovir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank